340B Drug Pricing Program

Louisiana Gov. John Bel Edwards June 19 signed into law state-level protections developed by the AHA. The Louisiana law prevents drug companies from denying, restricting, prohibiting or interfering with the acquisition or delivery of a 340B drug at a contract pharmacy.
AHA urges HRSA to restore policy for 340B hospitals with new outpatient facilities.
Over the past 30 years, the 340B Drug Pricing Program has played an essential role in ensuring health care providers have the necessary resources to provide vital programs and services for underserved patients and communities. Ongoing bipartisan support of the program is critical to ensuring…
The AHA May 25 published a report on the 340B Drug Pricing Program, its history and value to hospitals and patients, and details on 340B contract pharmacy arrangements. 
AHA, 340B hospitals and stakeholders voice concerns with two pieces of legislation that were recently passed out of the House Energy and Commerce Committee’s Health Subcommittee.
AHA, others voice strong opposition to 340B proposals being considered by House E&C Committee
The House Energy and Commerce Subcommittee on Health yesterday advanced a series of health care bills, and voted to pass and send to the full committee a bill that would impose additional reporting requirements on hospitals that participate in the 340B Drug Pricing Program.